Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 CAD | -1.23% | -4.17% | -51.94% |
05-14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
05-14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.94% | 19.3M | |
+42.17% | 50.93B | |
-0.38% | 42.12B | |
+49.62% | 42.05B | |
-7.20% | 29.18B | |
+13.50% | 26.02B | |
-22.13% | 18.9B | |
+7.83% | 13.21B | |
+24.16% | 12.17B | |
+30.19% | 12.16B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Transcript : Aptose Biosciences Inc. - Shareholder/Analyst Call